An anticonvulsant drug used for the treatment of absence seizues. It is a derivative of succinimide. A T-type calcium channel blocker. Reference standards of Ethosuximide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Ethosuximide
Catalogue No.:PA 05 29000
CAS :
Molecular Formula : C7H11NO2
Molecular Weight : 141.17
2-Ethyl-2-methylsuccinic Acid
Catalogue No.:PA 05 29010
Molecular Formula : C7H12O4
Molecular Weight : 160.17
2-Ethyl-2-methyl-succinonitrile
Catalogue No.:PA 05 29510
Molecular Formula : C7H10N2
Molecular Weight : 122.17
(E/Z)-2-Cyano-3-methyl-2-pentenoic Acid Ethyl Ester-d3
Catalogue No.:PA STI 023090
Molecular Formula : C9H10D3NO2
Molecular Weight : 170.22
Ethosuximide-d3
Catalogue No.:PA STI 038380
Molecular Formula : C7H8D3NO2
Molecular Weight : 144.19
2-Ethyl-2-methyl-succinonitrile-d3
Catalogue No.:PA STI 039770
Molecular Formula : C7H7D3N2
Molecular Weight : 125.19
Ethosuximide (E2150000)
Catalogue No.:PA EPE2150000
Molecular Formula : NA
Molecular Weight : NA
Ethosuximide impurity A (E2250000)
Catalogue No.:PA EPE2250000
Catalogue No.:PA ICRS0307
Molecular Formula :
Ethosuximide (1264002)
Catalogue No.:PA USP1264002
ethosuximide (146RB)
Catalogue No.:PA BP146RB
3-(Methoxycarbonyl)-3-methylpentanoic Acid
Catalogue No.:PA 05 0291000
Molecular Formula : C8H14O4
Molecular Weight : 174.2
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
